Transient galactosemia detected by neonatal mass screening

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 281-284

  Ono, Hiroaki ^a   Mawatari, Hideo ^a   Mizoguchi, Nobuyuki ^a   Eguchi, Takaatsu ^a   Sakura, Nobuo ^a   Hamakawa, Mochiyuki ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Hiroshima City Medical Association   (Japan)

Author keywords

Liver dysfunction; Mass screening; Transient galactosemia

Indexed keywords

BILE ACID; GALACTOKINASE; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GALACTOSE PHOSPHATE; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

ARTICLE; BILE ACID BLOOD LEVEL; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME ASSAY; FEMALE; FOLLOW UP; GALACTOSEMIA; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; NEWBORN; NEWBORN SCREENING; PHYSICAL DEVELOPMENT; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; WEIGHT GAIN;

EID: 0032977867     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.1999.t01-1-01070.x     Document Type: Article

References (13)

1. 1 Taylor CJ, Rattenbury JM, Allen JC, Tulloh R. Transient neonatal galactosaemia. Arch. Dis. Child. 1988; 63: 1388-9.
2. 2 Raffel LJ, Cowan TM, Blitzer MG. Transient neonatal galactosaemia identified by newborn screening. J. Inher. Metab. Dis. 1993; 16: 894-5.
3. 3 Hansen RG, Mayes JS. Galactose-1-phosphate uridyl transferase. Methods Enzymol. 1966; 9: 713-18.
4. 4 Beutler E, Paniker NV, Trinidad F. An assay of red cell galactokinase. Biochem. Med. 1971; 5: 325-32.
5. 5 Mizoguchi N, Eguchi T, Sakura N, Ueda K. Erythrocyte galactokinase assay with high performance liquid chromatography. Clin. Chim. Acta 1993; 216: 145-51.
6. 6 Gitzelmann R, Steinmann B. Uridine diphosphate galactose 4-epimerase deficiency. Paediatr. Acta 1973; 28: 497-510.
7. 7 Vaccaro AM, Mustillo M, Mandara I, Salvioli R. Improved isoelectric focusing of normal and variant forms of erythrocyte galactose-1-phosphate uridyltransferase. Electrophoresis 1983; 3: 58-61.
8. 8 Gitzelmann R, Arbenz UV, Willi UV. Hypergalactosaemia and portosystemic encephalopathy due to persistence of ductus venosus Arantii. Eur. J. Pediatr. 1992; 151: 564-8.
9. 9 Maisawa S, Takasago V, Oyake Y, Maeta H, Fujisawa T. Patent ductus venosus with hypoplastic right hepatoportal system in a young child born with asymmetric intrauterine growth retardation. Eur. J. Pediatr. 1992; 151: 569-72.
10. 10 Matsumoto T, Okano R, Sakura N et al. Hypergalactosaemia in a patient with portal-hepatic venous and hepatic arteriovenous shunts detected by neonatal screening. Eur. J. Pediatr. 1993; 152: 990-2.
11. 11 Tygstrup N. Galactose and fructose metabolism in liver disease. In: Bianchi L, Gerok W, Landmann L et al. (eds). Falk Symposium No. 35, Liver in Metabolic Disease. MTP Ltd, Boston, 1983; 255-60.
12. 12 Sakura N, Mizoguchi N, Eguchi T et al. Elevated plasma bile acids in hypergalactosaemic neonates: A diagnostic clue to portosystemic shunts. Eur. J. Pediatr. 1997; 156: 716-18.
13. 13 Fugelseth D, Lindemann R, Liestøl K, Kiserud T, Langslet A. Ultrasonographic study of ductus venous in healthy neonates. Arch. Dis. Child. 1997; 77: 131-4.